Business Context and Reporting Period
This Form 8-K Current Report was filed by CorMedix Inc. on January 6, 2012. The filing addresses corporate governance changes, specifically the appointment of a new executive officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial statements or performance data.
Material Changes
On January 6, 2012, the Board of Directors appointed Brian Lenz as the Company's Chief Operating Officer (COO). This appointment recognizes an increase in Mr. Lenz's day-to-day responsibilities. He will retain his existing roles as Chief Financial Officer, Treasurer, and Secretary. His compensation remains unchanged under his existing employment agreement.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items. The document is limited to the disclosure of the officer appointment.
Investor Verification Points
- Confirm the effective date of Brian Lenz's appointment as Chief Operating Officer (January 6, 2012).
- Verify that Mr. Lenz's compensation package remains unchanged despite the new title.
- Note that Mr. Lenz continues to serve concurrently as CFO, Treasurer, and Secretary.
- Review Mr. Lenz's prior experience, including roles at Arno Therapeutics, VioQuest Pharmaceuticals, Smiths Detection Group, and KPMG.